A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
Recruiting · NCT05394831 · Registry updated 2025-05-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC | EGFR Mutant Advanced Non-small Cell Lung Cancer | Recruiting | Phase 1 / Phase 2 | 2025-05-16 | NCT05394831 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| J Ints Bio | 1 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 338 |
| Chao Family Comprehensive Cancer Center, University of California Irvine Healthcare | Orange | United States | 1 |
| Chungbuk National University Hospital | Cheongju-si | South Korea | 20 |
| Faculty of Medicine Ramathibodi Hospital, Mahidol University | Ratchathewi | Thailand | 3 |
| National Cancer Center | Goyang-si | South Korea | 1 |
| Samsung Medical Center | Seoul | South Korea | 375 |
| Seoul National University Hospital | Seoul | South Korea | 393 |
| The Catholic University, St. Mary's Hospital | Seoul | South Korea | 1 |
| The Catholic University, St. Vincent's Hospital | Suwon | South Korea | 1 |
| Yonsei University Health System, Severance Hospital | Seoul | South Korea | 1 |